Q1 Earnings Estimate for Ayr Wellness Issued By Roth Capital

Ayr Wellness Inc. (OTCMKTS:AYRWF) – Stock analysts at Roth Capital decreased their Q1 2025 earnings estimates for Ayr Wellness in a research report issued to clients and investors on Monday, March 10th. Roth Capital analyst W. Kirk now forecasts that the company will post earnings of ($0.34) per share for the quarter, down from their previous estimate of ($0.32). The consensus estimate for Ayr Wellness’ current full-year earnings is ($1.31) per share. Roth Capital also issued estimates for Ayr Wellness’ Q2 2025 earnings at ($0.32) EPS, FY2025 earnings at ($1.26) EPS and FY2026 earnings at ($1.14) EPS.

Ayr Wellness (OTCMKTS:AYRWF) last issued its earnings results on Thursday, March 6th. The company reported ($0.41) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.29) by ($0.12). The firm had revenue of $113.96 million during the quarter, compared to analysts’ expectations of $114.10 million. Ayr Wellness had a negative return on equity of 25.30% and a negative net margin of 48.17%.

Other research analysts have also recently issued reports about the stock. Roth Mkm decreased their target price on shares of Ayr Wellness from $3.50 to $3.00 and set a “buy” rating for the company in a report on Thursday, November 14th. Ventum Cap Mkts cut shares of Ayr Wellness from a “strong-buy” rating to a “hold” rating in a report on Friday, March 7th.

Ayr Wellness Stock Down 7.9 %

Shares of Ayr Wellness stock opened at $0.16 on Thursday. The company has a debt-to-equity ratio of 0.76, a quick ratio of 0.58 and a current ratio of 1.59. The stock has a market capitalization of $18.18 million, a PE ratio of -0.07 and a beta of 1.70. Ayr Wellness has a 52-week low of $0.16 and a 52-week high of $3.46. The company has a 50-day simple moving average of $0.40 and a two-hundred day simple moving average of $1.02.

Ayr Wellness Company Profile

Ayr Wellness Inc operates as a vertically-integrated multi-state cannabis operator that cultivates, manufactures, and retails cannabis products and branded cannabis packaged goods. It owns and operates a chain of cannabis retail stores under AYR, Liberty Health Sciences, and The Dispensary brand names.